Oncimmune Ltd.
Records under this name other than the patents Oncimmune Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 9 of 9 · Back to Oncimmune Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,714,938 | Immunoassay methods Term ended Ended no later than May 26, 2026 · From the USPTO record | Term ended | Ended no later than May 26, 2026 | From the USPTO record |
| US 9,719,984 | Immunoassay methods Term ended Ended no later than May 26, 2026 · From the USPTO record | Term ended | Ended no later than May 26, 2026 | From the USPTO record |
| US 8,592,169 | Tumour marker proteins and uses thereof Term ended Term ended Nov 13, 2023 · From the USPTO record | Term ended | Term ended Nov 13, 2023 | From the USPTO record |
| US 8,574,848 | Immunoassay methods Lapsed on the fee record Ended Nov 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2021 | From the USPTO record |
| US 9,696,319 | Tumour markers Term ended Term ended Feb 2, 2021 · From the USPTO record | Term ended | Term ended Feb 2, 2021 | From the USPTO record |
| US 8,114,604 | Tumour markers Term ended Term ended Nov 27, 2019 · From the USPTO record | Term ended | Term ended Nov 27, 2019 | From the USPTO record |
| US 7,402,403 | Tumour markers Term ended Term ended May 11, 2019 · From the USPTO record | Term ended | Term ended May 11, 2019 | From the USPTO record |
| US 7,205,117 | Cancer detection method and reagents Lapsed on the fee record Ended Apr 17, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2019 | From the USPTO record |
| US 8,927,223 | Immunoassay methods Lapsed on the fee record Ended Jan 6, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 6, 2019 | From the USPTO record |